2 top ASX growth shares that might be worth buying

Volpara is one of the top ASX growth shares to consider.

| More on:
ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors may be interested in some ASX growth shares that have been delivering underlying growth for a while now.

Businesses that are achieving good revenue growth may be able to grow profit nicely over the coming years. Profit can be a key driver of share price growth over time.

That's why these two leading ASX growth shares could be quality ideas to think about:

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology business that provides software relating to screening for breast cancer and screening for lung cancer.

In the first quarter of FY22, Volpara reported that its subscription-based cash receipts were up around 38% to NZ$6.1 million. In constant currency terms, this was an increase of 60%.

Volpara is seeing steady growth in multiple areas. For example, its coverage of US women being screened was 33%, up from the prior quarter of 32%. Not only is the market share of women increasing, but the average revenue per user (ARPU) is also rising.

ARPU in that FY22 first quarter was US$1.42, an increase from US$1.40 at the end of the fourth quarter of FY21. The average ARPU for the first quarter was US$1.55. ARPU of up to US$5.87 was achieved at some sites.

Volpara's client loyalty remains high, with software as a service (SaaS) churn continuing to remain low.

The ASX growth share has a very high gross profit margin – it was 91% in FY21. This means that a lot of the new revenue can translate into gross profit.

The acquisition of CRA Health and expansion in the US lung cancer screening market are both promising. Volpara Lung currently covers around 8% of US lung cancer screening.

Betashares Asia Technology Tigers ETF (ASX: ASIA)

Over six months, this exchange-traded fund (ETF) has fallen 14%. But that gives investors the opportunity to look at it at a lower valuation.

The purpose of this investment is to give exposure to 50 of the largest Asian technology businesses outside of Japan in a single portfolio.

BetaShares says that:

Due to its younger, tech-savvy population, Asia is surpassing the West in terms of technological adoption and the sector is anticipated to remain a growth sector.

The ETF provider also points out that this investment can be used as a complement for investors to get Asian tech exposure alongside the US

So what's actually in the portfolio? There are six positions with a weighting of more than 5%: Taiwan Semiconductor Manufacturing (11.4%), Samsung Electronics (10%), Tencent (9.8%), Alibaba (8.7%), Meituan (6.6%) and Sea (5.7%). The other top 10 positions all have a weighting of at least 3%: JD.com (4.9%), Infosys (4.7%), Pinduoduo (4.4%) and Netease (3%).

These businesses come from a range of different sectors. E-commerce, semiconductors, gaming, technology hardware, entertainment, IT consulting and so on are all represented.

It has an annual management fee of 0.67%. Despite that fee, since inception to August 2018, it had produced an average return per annum of almost 23%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF and VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

3 stellar ASX growth shares to buy with $7,000

Let's see why analysts are feeling bullish about these top stocks.

Read more »

A smiling man at a shop counter takes payment from a customer, with racks of plants in the background.
Growth Shares

2 ASX shares to buy and hold for the next decade

I’m optimistic about what these investments can deliver in a year.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

High-conviction ASX 200 shares with 10-year upside

Let's see why analysts think these shares could be great long term picks.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Growth Shares

The ultimate Australian stocks to buy and hold for 10+ years

These shares could be ultimate buys according to analysts.

Read more »

A smiling man take a big bite out of a burrito
Growth Shares

Looking for ASX growth shares? I rate these 2 as buys

I’m backing these investments to deliver big returns.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

Macquarie says these ASX 200 growth shares can rise 20% to 35%

Let's see what the broker is saying about these growing companies.

Read more »

Growth Shares

Why Zip shares and this ASX 200 stock are a buy according to this fund manager

These stocks could be leading contenders to deliver returns in the ASX 200.

Read more »

A man working in the stock exchange.
Growth Shares

Buy these 2 impressive ASX 300 shares in July: experts

Experts are bullish on these stocks.

Read more »